Patent · US Active

Modulation of PTPRA to treat arthritis

US10604585B2 · kind B2 · utility

0Cited by
0References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 9, 2015
Grant dateMar 31, 2020
Priority date—
Expiry dateSep 9, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2440/14
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Presented is a method for treating inflammation and autoimmune diseases through the use of a phosphatase rheumatoid arthritis (PT-PRA) antagonist.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.